Haleon PLC (GB:HLN) has released an update.
Haleon PLC continues to strengthen its financial position by executing a share buyback on September 18, 2024, purchasing 650,166 shares for cancellation as part of its previously announced Buyback Programme. The transaction, involving shares bought at prices ranging from 395.1000 to 400.5000 pence, leaves Haleon with a total of 9,117,176,266 ordinary shares in its registered share capital. As a global consumer health leader, Haleon is known for its trusted brands across various health categories, including Advil and Sensodyne.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
